Results 31 to 40 of about 152,056 (303)

Real-World Prescribing Patterns for Hypertensive Children in China from 2018 to 2021: A Cross-Sectional Multicenter Study

Risk Management and Healthcare Policy, 2023
Qin Qian,* Yu-Zhen Wang,* Lian-Di Kan,* Jie Chen, Chen Wang, Gang Han, Liu-Cheng Li, Wei-Jian Lou Department of Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, People’s Republic of China&ast ...
Qian Q, Wang YZ, Kan LD, Chen J, Wang C, Han G, Li LC, Lou WJ   +7 more
doaj  

Efficacy of Huangqi Injection in the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis

Frontiers in Medicine, 2022
BackgroundHuangqi injection (HQI) is the extract of Astragalus membranaceus (Fisch.) Bunge, which is widely used in the treatment of a variety of diseases in China.
ZhongChi Xu, LiChao Qian, RuGe Niu, Ying Yang, ChunLing Liu, Xin Lin   +5 more
doaj   +1 more source

Relationship between antihypertensive medications and cognitive impairment: Part I. review of human studies and clinical trials [PDF]

, 2016
Purpose of review: There is an established association between hypertension and increased risk of poor cognitive performance and dementia including Alzheimer’s disease; however, associations between antihypertensive medications (AHMs) and dementia risk ...
Anstey, KJ, Carlson, MC, Peters, J, Peters, R, Schuchman, M, Yasar, S   +5 more
core   +2 more sources

THE APPLICATION OF COMBINED PREPARATIONS WITH CONSTANT DOSES OF ANTIHYPERTENSIVE DRUGS AS THE INITIAL TACTICS OF TREATMENT AT HIGH BLOOD PRESSURE LEVEL: PROVEN FACTS AND EXPERT’S OPINION

Евразийский Кардиологический Журнал, 2021
In this article the current problems of the use of combined antihypertensive drugs in the implementation of «tactics one tablet» in a wide range of patients with arterial hypertension are discussed.
S. R. Gilyarevskij, N. G. Bendeliani, M. V. Golshmid, I. M. Kuz’mina, I. G. Andreeva   +4 more
doaj   +1 more source

Antihypertensive drug therapy [PDF]

Annals of Translational Medicine, 2018
Lifestyle measures plus antihypertensive drug therapy should be used to treat adults with hypertension (1-4). Adults with clinical cardiovascular disease (coronary heart disease, heart failure, and stroke) should have their blood pressure reduced below 130/80 mmHg for secondary prevention of recurrent cardiovascular disease events (4).
openaire   +2 more sources

Off-label Utilization of Antihypertensive Medications in Children [PDF]

, 2007
Objective— To examine off-label utilization and costs of antihypertensive drugs in children using a national sample of prescription claims. Design— Cross-sectional study.
Albert Rocchini, August, Bajcetic, Blumer, Conroy, Cote, Cuttler, Esther Y. Yoon, Hopwood, Jen-Jar Lin, Kevin J. Dombkowski, Matthew M. Davis, McIntyre, Pandolfini, Shah, Steinbrook, Turner, t’ Jong, t’ Jong, t’ Jong, Wilson, Yoon   +21 more
core   +1 more source

An Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry (UPLC–MS/MS) Method for Qualifying DAPB in Rat Plasma and Application to Pharmacokinetic Studies

Molecules
DAPB, a new molecule including danshensu, borneol, and a mother nucleus of ACEI (Angiotensin-converting enzyme inhibitors), is being developed as an antihypertensive candidate compound.
Bei Qin, Yunmei Chen, Kuan Yang, Rong Wang, Lili Yu, Nana Wang, Shaojing Liu   +6 more
doaj   +1 more source

Personalized medicine—a modern approach for the diagnosis and management of hypertension [PDF]

, 2017
The main goal of treating hypertension is to reduce blood pressure to physiological levels and thereby prevent risk of cardiovascular disease and hypertension-associated target organ damage.
Borghi, Claudio, Grassi, Guido, Rosei, Enrico Agabiti, Savoia, Carmine, Touyz, Rhian M., Volpe, Massimo   +5 more
core   +1 more source

Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts. [PDF]

, 2020
Background and objectives: 2018 ESC/ESH Hypertension guideline recommends 2-drug combination as initial anti-hypertensive therapy. However, real-world evidence for effectiveness of recommended regimens remains limited.
Cho, Jaehyeong, Hripcsak, George, Jung, Sungjae, Lee, Seongwon, Park, Rae Woong, Park, Sungha, Ryan, Patrick B, Schuemie, Martijn J, Suchard, Marc A, Swerdel, Joel N, You, Seng Chan   +10 more
core   +2 more sources

Study on the Excretion of a New Antihypertensive Drug 221s (2,9) in Rats

Pharmaceuticals
Background/Objectives: The novel compound 221s (2,9), derived from danshensu and ACEI-active proline, exhibits antihypertensive effects (50/35 mmHg SBP/DBP reduction in SHRs) with potential cough mitigation.
Yunmei Chen, Kuan Yang, Shaojing Liu, Lili Yu, Rong Wang, Bei Qin   +5 more
doaj   +1 more source